Neurocrine Biosciences, Inc.
NBIX Healthcare Drug Manufacturers Specialty & Generic
Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024. In the quarter to June 2026, revenue grew 39.5%, EPS grew 31.2% and free cash flow grew 43.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.
Follow NBIX
Neurocrine Biosciences, Inc. (NBIX) P/E ratio
As of 16 October 2026, Neurocrine Biosciences, Inc. (NBIX) trades at a P/E ratio of 19.2×. Over the past ten years it has ranged from 0.0× (June 2019) to 1,244× (October 2018); the current reading is higher than 35% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 29.4× | (27.14%) |
| FY2024 | 40.4× | (22.13%) |
| FY2023 | 51.9× | (30.46%) |
| FY2022 | 74.6× | (16.81%) |
| FY2021 | 89.7× | 307.81% |
| FY2020 | 22.0× | (91.82%) |
| FY2019 | 269× | (17.21%) |
| FY2018 | 325× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 23.9× | 21.76% |
| Mar 2026 | 19.6× | (33.28%) |
| Dec 2025 | 29.4× | (9.66%) |
| Sep 2025 | 32.6× | (9.82%) |
| 35 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| HIMS Hims & Hers Health, Inc. compare | n/m |
| VTRS Viatris Inc. compare | n/m |
| ELAN Elanco Animal Health Incorporated compare | n/m |
| UTHR United Therapeutics Corporation compare | 17.6× |
| NBIX Neurocrine Biosciences, Inc. | 19.2× |
| LNTH Lantheus Holdings, Inc. compare | 23.7× |
| RDY Dr. Reddy's Laboratories Ltd compare | 32.9× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 73.4× |
| ALKS Alkermes plc compare | 102× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)